An Open-Label Phase 1 Study to evaluate the safety and Efficacy of AB-1015 in Patients with Platinum-Resistant Epithelial Ovarian Cancer
![](https://researchstudies.cuanschutz.edu/Content/images/study-category-images/cancer.jpg)
Details
Age
Adult
Locations
CTRC Inpatient
University of Colorado Hospital
Principal Investigator
![Photograph of Bradley Corr](https://som.ucdenver.edu/FIMS/Content/faculty/21500/CU-Doctors-21500.jpg)
Bradley Corr
Study ID
Protocol Number: 23-0956
More information available at ClinicalTrials.gov: NCT05617755
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers